Sundaram Multi Pap (BOM:533166) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


BOM:533166 Sundaram Multi Pap Ltd BOM:533166
73 GF Score
Price ₹1.32
GF Value ₹2.82
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sundaram Multi Pap Research & Development?

Sundaram Multi Pap BOM:533166 +0.76% 73 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:533166 with a GF Score™ of 73/100 and a GF Value™ of ₹2.82 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sundaram Multi Pap's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Sundaram Multi Pap  (BOM:533166) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sundaram Multi Pap Research & Development Related Terms

Sundaram Multi Pap Research & Development Historical Data

* Premium members only.

The historical data trend for Sundaram Multi Pap's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sundaram Multi Pap Research & Development Chart

Sundaram Multi Pap Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sundaram Multi Pap Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:533166
73GF Score
Sundaram Multi Pap Ltd BOM:533166
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sundaram Multi Pap Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Sundaram Multi Pap (BOM:533166) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Sundaram Multi Pap and its competitors.
Is Sundaram Multi Pap's Research & Development too high?
Sundaram Multi Pap's current Research & Development is ₹0 Mil. Overall, Sundaram Multi Pap has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sundaram Multi Pap's Research & Development compare to competitors?
Sundaram Multi Pap's Research & Development of ₹0 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Forest Products company?
A good Research & Development depends on the Forest Products industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sundaram Multi Pap and its competitors. Sundaram Multi Pap's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundaram Multi Pap stock overvalued right now?
Based on GuruFocus' analysis, Sundaram Multi Pap (BOM:533166) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹2.82, compared to a current price of ₹1.32 — trading 53.2% below its estimated fair value. The current Research & Development is ₹0 Mil. Sundaram Multi Pap's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sundaram Multi Pap (BOM:533166), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sundaram Multi Pap (BOM:533166) Overvalued in 2026?

Based on GuruFocus' analysis, Sundaram Multi Pap stock appears to be undervalued. The current stock price of ₹1.32 is trading 53.2% below its estimated GF Value™ of ₹2.82. GuruFocus considers Sundaram Multi Pap to be Significantly Undervalued.

Key valuation signals for BOM:533166:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹2.82 vs. price of ₹1.32 (53.2% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the BOM:533166 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sundaram Multi Pap Business Description

Other Exchanges SUNDARAM:India
Address Suren Road, Andheri Kurla Road, Unit No. 5/6, Ground Floor, Papa Industrial Estate, Chakala, Andheri (East), Mumbai, MH, IND, 400093
Sundaram Multi Pap Ltd is a manufacturer of paper and stationery products in India. The company designs, manufactures, and markets paper stationery products. The products include exercise notebooks, long books, notepads, scrapbooks, drawing books, and graph books for students of all ages, as well as office or corporate stationery products and printing, writing, and packaging paper. In addition, the company is also engaged in the business of e-learning.
73GF Score

Get the complete analysis for BOM:533166

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1.32
Price
₹2.82
GF Value